However, lipid abnormalities are common, and may only be transiently abnormal. Therefore, physician judgement and discretion in testing must be foremost when considering the study of dyslipidemia in patients. The intent of this guideline is to emphasize primary and secondary screening options and discretionary testing, based on scientific evidence.
Primary prevention is aimed at identifying dyslipidemia before disease complications occur.
See Table 1 for Risk Assessment and Testing Recommendations for Secondary and Primary Prevention. This intervention has the greatest short term impact. When dyslipidemia is documented, the decision to modify risk factors must include consideration of dietary modification and correction of life style. TG to calculate LDL-C. Recheck and treat. Recheck every 2 - 4 months until level stablizes, then once per year.